Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome
- PMID: 15158632
- PMCID: PMC7112423
- DOI: 10.1016/S0140-6736(04)16255-7
Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome
Abstract
Severe acute respiratory syndrome (SARS) is thought to be caused by a novel coronavirus, SARS-associated coronavirus. We studied viral shedding of SARS coronavirus to improve diagnosis and infection control. Reverse-transcriptase PCR was done on 2134 specimens of different types. 355 (45%) specimens of nasopharyngeal aspirates and 150 (28%) of faeces were positive for SARS coronavirus RNA. Positive rates peaked at 6-11 days after onset of illness for nasopharyngeal aspirates (87 of 149 [58%], to 37 of 62 [60%]), and 9-14 days for faeces (15 of 22 [68%], to 26 of 37 [70%]). Overall, peak viral loads were reached at 12-14 days of illness when patients were probably in hospital care, which would explain why hospital workers were prone to infection. Low rate of viral shedding in the first few days of illness meant that early isolation measures would probably be effective.
Similar articles
-
Nasopharyngeal detection of severe acute respiratory syndrome-associated coronavirus RNA in health-care workers.Chest. 2006 Jan;129(1):12-3. doi: 10.1378/chest.129.1.12. Chest. 2006. PMID: 16424407 Free PMC article. No abstract available.
-
Colonization of severe acute respiratory syndrome-associated coronavirus among health-care workers screened by nasopharyngeal swab.Chest. 2006 Jan;129(1):95-101. doi: 10.1378/chest.129.1.95. Chest. 2006. PMID: 16424418 Free PMC article.
-
Severe acute respiratory syndrome-associated coronavirus in lung tissue.Emerg Infect Dis. 2004 Jan;10(1):20-4. doi: 10.3201/eid1001.030404. Emerg Infect Dis. 2004. PMID: 15078592 Free PMC article.
-
Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.Curr Opin Pulm Med. 2014 May;20(3):233-41. doi: 10.1097/MCP.0000000000000046. Curr Opin Pulm Med. 2014. PMID: 24626235 Review.
-
Severe acute respiratory syndrome: global initiatives for disease diagnosis.QJM. 2003 Nov;96(11):845-52. doi: 10.1093/qjmed/hcg146. QJM. 2003. PMID: 14566040 Free PMC article. Review.
Cited by
-
COVID-19 Pandemic: from Molecular Biology, Pathogenesis, Detection, and Treatment to Global Societal Impact.Curr Pharmacol Rep. 2020;6(5):212-227. doi: 10.1007/s40495-020-00229-2. Epub 2020 Jul 27. Curr Pharmacol Rep. 2020. PMID: 32837855 Free PMC article. Review.
-
Minimizing disease spread on a quarantined cruise ship: A model of COVID-19 with asymptomatic infections.Math Biosci. 2020 Nov;329:108442. doi: 10.1016/j.mbs.2020.108442. Epub 2020 Aug 7. Math Biosci. 2020. PMID: 32777227 Free PMC article.
-
Factors affecting the risk of SARS-CoV-2 transmission to anesthesiologists performing endotracheal intubation in patients with SARS-CoV-2.Am J Transl Res. 2021 Apr 15;13(4):1915-1927. eCollection 2021. Am J Transl Res. 2021. PMID: 34017367 Free PMC article.
-
Dexamethasone in Hospitalized Patients with Covid-19.N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17. N Engl J Med. 2021. PMID: 32678530 Free PMC article. Clinical Trial.
-
Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentrates.Transfus Med. 2005 Aug;15(4):269-76. doi: 10.1111/j.0958-7578.2005.00588.x. Transfus Med. 2005. PMID: 16101804 Free PMC article.
References
-
- WHO Severe acute respiratory syndrome (SARS): multi-country outbreak—update 34. http://www.who.int/csr/don/2003_04_19/en/ (accessed March 22, 2004).
-
- WHO Case definitions for surveillance of severe acute respiratory syndrome (SARS) http://www.who.int/csr/sars/casedefinition/en/ (accessed March 22, 2004).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous